Center on Health Equity & Access

Clinical

Health Care Cost

Health Care Delivery

Insurance

Policy

Technology

Value-Based Care

News

All News

Press Releases

Product Approvals and Launches

Video

All Video Types

AJMC TV

Insights

OnLocation

Payer Perspectives

Peer Exchange

Post Conference Perspectives

Stakeholder Summit

Podcasts

Conferences

Conference Coverage

Conference Listing

Journals

All Journals

The American Journal of Managed Care

Population Health, Equity & Outcomes

Evidence-Based Oncology

About Supplements and Featured Publications

Supplements and Featured Publications Issues

Submit a Manuscript

Events

Institute for Value-Based Medicine

Patient-Centered Oncology Care

Resources

Interactive Tools

Clinical Spotlight

Microsites

About AJMC

AJMC Staff

Anniversary

Seema Sonnad Award

Strategic Alliance Partners

Subscribe

Cameron Santoro is an associate editor for 

), AJMC.com, and The Center for Biosimilars

Articles

Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.

Alopecia Areata Risk in Patients With IBD Tied to Anti-TNF Use

, MD, FAAP, was the former chief medical officer of the US Medicaid program. He is the managing partner at Social Innovation Ventures, where he invests in and advises companies and nonprofits dedicated to eliminating disparities. He also advises federal and state regulators on how to incorporate human-centered design into policymaking.

In the wake of the Inflation Reduction Act and other regulatory changes, Medicare Advantage plans have braced for significant cuts that are forcing them to take a hard look at their product offering. 

Contributor: Vulnerable Seniors Are at Risk with Looming Medicare Advantage Cuts—Income-Based Programs Can Minimize the Damage 

Novel evidence has emerged from a 16-year study that hidradenitis suppurativa can elevate risks of not only pregnancy and postpartum complications, but of morbidity—particularly metabolic- and immunology-related morbidity—for mother and child in the long term.


With Hidradenitis Suppurativa, Maternal and Offspring Outcomes May Suffer

Report reveals growing divide between subsidized and unsubsidized enrollees.



ACA Enrollees Share Mixed Opinions Ahead of Open Enrollment, Upcoming Election

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.

About

Contact

Editorial Boards

Advertise

Do Not Sell My Information

Terms & Conditions

Privacy Policy

AJMC - Managed Care News, Research, and Expert Insights

Facebook

Twitter

LinkedIn

Instagram

Specialty Area

Biosimilars

Cardiorenalmetabolic

Dermatology

Hematology

Hepatology

Immunology

Infectious Disease

Mental Health

Neurology

Obesity

Oncology

Ophthalmology

Pulmonology

Rare Disease

Respiratory

Rheumatology

Women's Health

Spotlight

Free In-Person Regional Events Focused on Oncology and Population Health

Topics

Digital Health

Formulary

Gene Therapy

Guidelines

Health Care Administration

Population Health

All Coverage

Event Coverage

Interviews

AJMC Journals

Author Forms

Authors

Nominate a Rising Leader

View

Introduction

The Managed Care Pharmacy Perspective

Pharmacologic Characteristics of Progestins Used for Contraception and Hormone Replacement Therapy, Including New Transdermal Technologies

Managing the Transition from Oral Contraceptives to Hormone Replacement Therapy

Patient Communication and Counseling on Contraception and Hormone Replacement Therapy